About David Silbersweig
David Silbersweig is a director at Ceretype Neuromedicine.
David Silbersweig first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name David Silbersweig in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Silbersweig works with at each company, as listed on that company's latest Form D.
Ceretype Neuromedicine, Inc. · Form D, Dec 18, 2025
ES
Emily Stern
Chief Executive Officer and director
RL
Richard Lipkin
Director